SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 271 filers reported holding SEATTLE GENETICS INC in Q3 2017. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $11,000 | -87.2% | 93 | -87.6% | 0.00% | -80.0% |
| Q4 2019 | $86,000 | -23.2% | 749 | -42.7% | 0.01% | -28.6% |
| Q3 2019 | $112,000 | +24.4% | 1,307 | 0.0% | 0.01% | +40.0% |
| Q2 2019 | $90,000 | -6.2% | 1,307 | 0.0% | 0.01% | -16.7% |
| Q1 2019 | $96,000 | +29.7% | 1,307 | 0.0% | 0.01% | +20.0% |
| Q4 2018 | $74,000 | -26.7% | 1,307 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $101,000 | +16.1% | 1,307 | 0.0% | 0.01% | +20.0% |
| Q2 2018 | $87,000 | +27.9% | 1,307 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $68,000 | -2.9% | 1,307 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $70,000 | -1.4% | 1,307 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $71,000 | +4.4% | 1,307 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $68,000 | -17.1% | 1,307 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $82,000 | +18.8% | 1,307 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $69,000 | – | 1,307 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |